A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons (Georgia Wells/Wall Street Journal) Technology September 28, 2026 Featured Podcasts Lenny’s Podcast: The grief, loneliness, and burnout sweeping by the tech business proper now | Molly Graham Interviews…
Researchers used AI to design functional antibodies from scratch, suggesting that AI tools could speed up antibody discovery without the need for animal testing (Financial Times) Technology November 6, 2025 Featured Podcasts Nice Chat: Tech is getting extra political—must you? A podcast principally about tech. Delivered to you weekly by…
AbCellera gains on antibody collaboration with Biogen (NASDAQ:ABCL) Markets March 11, 2024 Love Worker AbCellera Biologics (NASDAQ:ABCL) is up ~3% in Monday buying and selling after saying a collaboration with Biogen (NASDAQ:BIIB)…
